Skip to main content
OpenTrials
Completed

NCT Number: NCT01916915

Usage of Tramadol With Levobupivacaine for Pain Treatment After Cesarean Section

Patients experience considerable amount of pain after cesarean section. The aim of this study is to investigate the effect of tramadol (an opioid pain killer) added to levobupivacaine (a local anesthetic) in continuous wound infusion (which is done by placing a catheter in the incision) after cesarean sections.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–45 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 4

Primary location

Ufuk University Dr Rıdvan Ege Hospital

Ankara, 06520, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Planned cesarean section
  • American Society of Anesthesiologists Class I-II

Exclusion criteria

  • Patients refusing to enroll in the study
  • Serious coagulopathy
  • Serious systemic disease
  • Story of allergy to drugs being used in the study
  • Morbid obesity (Body mass index > 30)

Treatment and study plan

Tramadol infusion via wound catheter

Drug

Levobupivacaine

Drug

Primary outcomes

  1. lowering of pain as measured by visual analogue scores

    Time frame: forty eight hours after the operation

Secondary outcomes

  1. total additional analgesic consumption

    Time frame: forty eight hours after the operation

Sponsors and collaborators

Lead sponsor

Ufuk University

Other

Registry information

Official study title

The Effect of Addition of Tramadol to Levobupivacaine in Continuous Wound Infusion for Postoperative Pain Treatment in Cesarean Section

Important dates

Study start
2013
Primary completion
2016
Study completion
2016
First posted
Aug 6, 2013
Registry last updated
Jun 29, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.